FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

ALSO NOTED: India funds training centers; Memory gains milestone;and much more...

Tools

> India is funding clinical research training centers around the country to help spur the country's involvement in drug research. Report

> Memory Pharmaceuticals has received a $2 million milestone for MEM 3454. Release

> VWR International has established a wholly owned subsidiary in Bangalore, India. Release

> EntreMed has begun a Phase II trial of Panzem for ovarian cancer. Release

> Regulators have approved Watson Pharmaceuticals' acquisition of Andrx. Report

> Researchers have grow a miniature liver from stem cells. Report

> Roche's Tamiflu ad campaign featuring penguins (picture) has sparked criticism. Report

And Finally... A new study that concludes a brain abnormality could be behind sudden infant death syndrome points may help researchers develop a new therapy. Article 


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Tamiflu   Andrx   ovarian cancer   Watson Pharmaceuticals